Join our growing community to challenge mainstream media bias and fix the news
Pfizer, BioNTech to submit emergency use authorization request for vaccine

Pfizer, BioNTech to submit emergency use authorization request for vaccine

Pfizer and BioNTech intend to apply for an emergency use authorization (EUA) from the Food and Drug Administration (FDA) for their coronavirus vaccine on November 20th. The FDA review process is anticipated to take a few weeks and could be completed in early December. If the EUA is approved, roll-out of the vaccine is likely to start from health-care workers and those in risk-groups for COVID-19.

Karlo
Karlo
Top in Business